Menu
Back to User profile » Dr Ciprian Tomuleasa
Papers published by Dr Ciprian Tomuleasa:
Castleman’s Disease in the HIV-Endemic Setting [Retraction]
Mahroug E, Sher-Locketz C, Desmirean M, Abayomi EA, Tomuleasa C, Grewal R
Cancer Management and Research 2020, 12:7465-7466
Published Date: 20 August 2020
Castleman’s disease in the HIV-endemic setting
Mahroug E, Sher-Locketz C, Desmirean M, Abayomi EA, Tomuleasa C, Grewal R
Cancer Management and Research 2018, 10:4553-4563
Published Date: 12 October 2018
The role of the pathology department in the preanalytical phase of molecular analyses
Susman S, Berindan-Neagoe I, Petrushev B, Pirlog R, Florian IS, Mihu CM, Berce C, Craciun L, Grewal R, Tomuleasa C
Cancer Management and Research 2018, 10:745-753
Published Date: 12 April 2018
Adult acute megakaryoblastic leukemia: rare association with cytopenias of undetermined significance and p210 and p190 BCR–ABL transcripts
Dima D, Oprita L, Rosu AM, Trifa A, Selicean C, Moisoiu V, Frinc I, Zdrenghea M, Tomuleasa C
OncoTargets and Therapy 2017, 10:5047-5051
Published Date: 19 October 2017
The new era of nanotechnology, an alternative to change cancer treatment
Jurj A, Braicu C, Pop LA, Tomuleasa C, Gherman CD, Berindan-Neagoe I
Drug Design, Development and Therapy 2017, 11:2871-2890
Published Date: 27 September 2017
The use of rotation to fentanyl in cancer-related pain
Dima D, Tomuleasa C, Frinc I, Pasca S, Magdo L, Berindan-Neagoe I, Muresan M, Lisencu C, Irimie A, Zdrenghea M
Journal of Pain Research 2017, 10:341-348
Published Date: 9 February 2017
In vivo assessment of bone marrow toxicity by gold nanoparticle-based bioconjugates in Crl:CD1(ICR) mice
Berce C, Lucan C, Petrushev B, Boca S, Miclean M, Sarpataki O, Astilean S, Buzoianu A, Tomuleasa C, Bojan A
International Journal of Nanomedicine 2016, 11:4261-4273
Published Date: 1 September 2016
Gold nanoparticles enhance the effect of tyrosine kinase inhibitors in acute myeloid leukemia therapy
Petrushev B, Boca S, Simon T, Berce C, Frinc I, Dima D, Selicean S, Gafencu GA, Tanase A, Zdrenghea M, Florea A, Suarasan S, Dima L, Stanciu R, Jurj A, Buzoianu A, Cucuianu A, Astilean S, Irimie A, Tomuleasa C, Berindan-Neagoe I
International Journal of Nanomedicine 2016, 11:641-660
Published Date: 15 February 2016
Small molecules against B-RAF (BRAF) Val600Glu (V600E) single mutation
Zaharie F, Cojocneanu-Petric R, Muresan M, Frinc I, Dima D, Petrushev B, Tanase A, Berce C, Chitic M, Berindan-Neagoe I, Pileczki V, Irimie A, Tomuleasa C
International Journal of Nanomedicine 2015, 10:4897-4899
Published Date: 31 July 2015
Bicytopenia as a paraneoplastic syndrome for pseudomyxoma peritonei. Hematologic manifestations of a subtle disease
Tomuleasa C, Petrushev B, Vedean M, Irimie A, Zaharie F, Rosu AM, Dima D, Cucuianu A
International Journal of General Medicine 2015, 8:93-95
Published Date: 2 March 2015
Dose intensity and autologous stem cell transplantation as salvage therapy for pediatric primary CNS malignancies
Kojima S, Cucuianu A, Takahashi Y, Berindan-Neagoe I, Florian IS, Dima D, Tomuleasa C
International Journal of Nanomedicine 2014, 9:3247-3248
Published Date: 4 July 2014
MRI-based identification of undifferentiated cells: looking at the two faces of Janus
Tomuleasa C, Florian IS, Berce C, Irimie A, Berindan-Neagoe I, Cucuianu A
International Journal of Nanomedicine 2014, 9:865-866
Published Date: 11 February 2014
Sorafenib for the treatment of solid malignancies: what about the cancer microenvironment?
Tomuleasa C, Cucuianu A, Aldea M, Berindan-Neagoe I
International Journal of Nanomedicine 2013, 8:4043-4044
Published Date: 23 October 2013